These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28901456)

  • 1. The antitumor effects of arsenic trioxide in mantle cell lymphoma via targeting Wnt/β‑catenin pathway and DNA methyltransferase-1.
    Li XY; Li Y; Zhang L; Liu X; Feng L; Wang X
    Oncol Rep; 2017 Nov; 38(5):3114-3120. PubMed ID: 28901456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma.
    Jung HJ; Chen Z; McCarty N
    Am J Hematol; 2012 Dec; 87(12):1057-64. PubMed ID: 22965904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.
    Lo RK; Kwong YL
    Ann Hematol; 2014 Feb; 93(2):255-65. PubMed ID: 23949314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
    Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ
    Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of arsenic trioxide on induction of apoptosis in MCL cell line and its possible mechanisms].
    Fei AM; Mao CM; Liu JJ; Zhu J; Mi JQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):909-13. PubMed ID: 20723298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathways.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; Terol MJ; García-Marco JA; García-Pardo A
    Oncotarget; 2015 Dec; 6(42):44832-48. PubMed ID: 26540567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway.
    Zhang H; Gu H; Li L; Ren Y; Zhang L
    Tumour Biol; 2016 May; 37(5):5919-23. PubMed ID: 26592252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
    Chen G; Wang Y; Huang H; Lin F; Wu D; Sun A; Chang H; Feng Y
    Eur J Haematol; 2009 Mar; 82(3):176-83. PubMed ID: 19077051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
    Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
    Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
    Emruli VK; Olsson R; Ek F; Ek S
    BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells.
    Eyvani H; Moghaddaskho F; Kabuli M; Zekri A; Momeny M; Tavakkoly-Bazzaz J; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Life Sci; 2016 Dec; 167():67-77. PubMed ID: 27769816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q; Li Y; Deng J; Zhang Z
    Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines.
    Peng CY; Jiang J; Zheng HT; Liu XS
    Leuk Lymphoma; 2010 Feb; 51(2):297-303. PubMed ID: 20038232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA induces apoptosis via inhibition of Wnt/β‑catenin/MGMT signaling in AtT‑20 cells.
    Li ZY; Huang GD; Chen L; Zhang C; Chen BD; Li QZ; Wang X; Zhang XJ; Li WP
    Mol Med Rep; 2017 Nov; 16(5):5908-5914. PubMed ID: 28849207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic Trioxide Induces Retinoic Acid-Related Orphan Receptor Beta and Blocks the WNT Pathway to Inhibit Stemness in Glioblastoma.
    Ding D; Gao K; Zhang X; Wang H
    Tohoku J Exp Med; 2024 Sep; 263(3):199-210. PubMed ID: 38797699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
    Lam SK; Mak JC; Zheng CY; Li YY; Kwong YL; Ho JC
    Int J Oncol; 2014 Jun; 44(6):2093-102. PubMed ID: 24691991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide inhibits DNA methyltransferase and restores expression of methylation-silenced CDKN2B/CDKN2A genes in human hematologic malignant cells.
    Fu HY; Shen JZ; Wu Y; Shen SF; Zhou HR; Fan LP
    Oncol Rep; 2010 Aug; 24(2):335-43. PubMed ID: 20596618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9.
    Amigo-Jiménez I; Bailón E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
    Oncotarget; 2016 Dec; 7(50):83359-83377. PubMed ID: 27829220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.